No profile data available.
BioHarvest Sciences Inc. (BHST) is a healthcare company in the functional food supplements industry, based in Vancouver, Canada, with about 89 full-time employees.
It reported revenue of $34.51 million for fiscal year 2025, up 37.0% from fiscal year 2024, and net income of -$11.14 million. Its largest business segment, Products, brought in 95% of segment revenue in fiscal year 2025; North America was the largest region with 89%. Its market capitalization was $37.63 million as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of October 9, 2026.
BioHarvest Sciences Inc. operates as a biotechnology company in Israel and the United States. It operates through two segments: Products and CDMO Services. The company develops botanical synthesis platform technology to produce plant cells with higher concentrations of active ingredients.
BioHarvest Sciences reported $34.51 million in revenue for fiscal year 2025, up 37.0% from $25.19 million in fiscal year 2024.
Products, with $32.63 million or 95% of segment revenue in fiscal year 2025. Next: Cdmo Services (5%).
North America: 89% of revenue by region in fiscal year 2025, followed by Israel (11%).
$37.63 million as of October 9, 2026.